Loreto Carmona Selected Research

Abatacept (Orencia)

7/2021	Influence of prognosis factors on the prescription of targeted treatments in rheumatoid arthritis: A Delphi survey.
1/2021	Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
8/2013	Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis.
1/2013	Abatacept use in rheumatoid arthritis: evidence review and recommendations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loreto Carmona Research Topics

Disease

36	Rheumatoid Arthritis 08/2023 - 04/2003
28	Rheumatic Diseases (Rheumatism) 12/2022 - 08/2003
12	Infections 04/2024 - 06/2005
11	Pain (Aches) 01/2022 - 07/2006
11	Gout 11/2021 - 10/2011
8	COVID-19 08/2023 - 01/2021
8	Neoplasms (Cancer) 01/2023 - 07/2007
8	Psoriatic Arthritis 01/2022 - 03/2012
8	Arthritis (Polyarthritis) 01/2022 - 01/2006
6	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 05/2006
6	Necrosis 01/2021 - 07/2007
5	Tuberculosis (Tuberculoses) 03/2021 - 08/2003
4	Connective Tissue Diseases (Connective Tissue Disease) 08/2023 - 07/2014
4	Joint Diseases (Joint Disease) 01/2022 - 01/2011
3	Vasculitis (Vasculitides) 08/2023 - 12/2021
3	Osteoarthritis 12/2022 - 03/2007
3	Ankylosing Spondylitis 01/2022 - 03/2012
3	Hypertension (High Blood Pressure) 01/2022 - 05/2014
3	Latent Tuberculosis 03/2021 - 06/2005
3	Osteoporosis 01/2018 - 11/2012
2	Herpes Zoster 12/2022 - 10/2010
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 02/2011
2	Fatigue 01/2022 - 09/2020
2	Spondylitis 01/2022 - 09/2020
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 09/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Bursitis (Adhesive Capsulitis) 01/2022 - 01/2021
2	Obesity 12/2021 - 11/2016
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 01/2019
2	Antisynthetase syndrome 01/2020 - 01/2019
2	Synovitis 12/2019 - 03/2011
2	Inflammation (Inflammations) 01/2015 - 09/2014
2	Drug-Related Side Effects and Adverse Reactions 12/2011 - 02/2011
2	Optic Neuritis (Retrobulbar Neuritis) 12/2011 - 02/2011
2	Demyelinating Diseases (Demyelinating Disease) 12/2011 - 02/2011
2	Multiple Sclerosis 12/2011 - 02/2011
1	Autoimmune Diseases (Autoimmune Disease) 05/2024
1	Food Hypersensitivity (Food Allergy) 05/2024
1	Systemic Scleroderma (Systemic Sclerosis) 05/2024
1	Metabolic Bone Diseases (Osteopenia) 12/2022
1	type 1 Stickler syndrome 12/2022
1	Cardiovascular Infections 12/2022
1	Myocardial Infarction 10/2022
1	Leukopenia 10/2022
1	Disease Progression 10/2022
1	Stroke (Strokes) 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022

Drug/Important Bio-Agent (IBA)

24	Tumor Necrosis Factor InhibitorsIBA 08/2023 - 08/2003
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 06/2005
12	GlucocorticoidsIBA 04/2024 - 02/2006
10	Antirheumatic Agents (DMARD)IBA 01/2023 - 04/2003
9	Uric Acid (Urate)IBA 11/2021 - 10/2011
6	Rituximab (Mabthera)FDA Link 01/2022 - 08/2013
5	AntibodiesIBA 12/2021 - 06/2012
5	Etanercept (Enbrel)FDA Link 10/2014 - 08/2003
4	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 06/2008
4	Abatacept (Orencia)FDA Link 07/2021 - 01/2013
4	artemisinin-naphthoquine combinationIBA 03/2020 - 05/2017
4	Rheumatoid FactorIBA 05/2019 - 07/2013
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2014 - 02/2009
4	ametantrone (HAQ)IBA 03/2011 - 10/2006
4	Infliximab (Remicade)FDA Link 03/2010 - 08/2003
3	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024 - 02/2011
3	Monoclonal AntibodiesIBA 10/2022 - 10/2014
3	secukinumabIBA 01/2022 - 09/2020
3	Prednisolone (Predate)FDA LinkGeneric 01/2022 - 01/2021
3	tocilizumab (atlizumab)FDA Link 01/2021 - 08/2013
3	SteroidsIBA 01/2018 - 07/2006
3	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 09/2014
3	Colchicine FDA LinkGeneric 09/2014 - 09/2014
3	Adalimumab (Humira)FDA Link 03/2010 - 01/2006
2	ORALIT (ORS)IBA 01/2023 - 12/2021
2	Janus Kinase InhibitorsIBA 12/2022 - 01/2021
2	VaccinesIBA 01/2022 - 01/2022
2	Oxygen (Dioxygen)IBA 12/2021 - 01/2021
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 11/2021 - 10/2014
2	PowdersIBA 11/2021 - 10/2014
2	antineoplaston A10 (A 10)IBA 11/2021 - 10/2014
2	Lactose FDA LinkGeneric 11/2021 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2018
2	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2018
2	OsteoprotegerinIBA 01/2021 - 01/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2021
2	Allopurinol (Remid)FDA LinkGeneric 07/2015 - 07/2015
2	tofacitinibIBA 01/2015 - 10/2014
2	canakinumab FDA Link 09/2014 - 09/2014
2	Interleukin-1 (Interleukin 1)IBA 09/2014 - 09/2014
2	insulin receptor-related receptor (IRR)IBA 08/2011 - 06/2008
1	Intravenous Immunoglobulins (IVIG)FDA Link 05/2024
1	Immunoglobulin E (IgE)IBA 05/2024
1	Vasodilator Agents (Vasodilators)IBA 05/2024
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 08/2023
1	CollagenIBA 12/2022

Therapy/Procedure

17	Biological Therapy 03/2021 - 09/2010
16	Therapeutics 05/2024 - 05/2006
3	Transitional Care 01/2017 - 10/2015
2	Nursing Care 12/2022 - 03/2015
1	Immunotherapy 05/2024
1	Aftercare (After-Treatment) 10/2022